Therapixel
Therapixel develops artificial intelligence software specifically designed for medical imaging analysis. Its primary product, MammoScreen, assists radiologists in the detection of breast cancer within screening mammograms. The company provides these diagnostic support tools to clinics, hospitals, and national provider networks to improve the accuracy of cancer screenings.
Healthtech
Artificial Intelligence
Medical Imaging
Radiology
Funding summary
- Total raised
- €20.6M
- Funding rounds
- 3
Investors in Therapixel
Investors on record for Therapixel. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Therapixel?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors